Immunotherapy alleviates amyloid-associated synaptic pathology in an Alzheimer’s disease mouse model

Cognitive decline in Alzheimer’s disease is attributed to loss of functional synapses, most likely caused by synaptotoxic, oligomeric forms of amyloid-β. Many treatment options aim at reducing amyloid-β levels in the brain, either by decreasing its production or by increasing its clearance. We quant...

Descripción completa

Detalles Bibliográficos
Autores principales: Dorostkar, Mario M., Burgold, Steffen, Filser, Severin, Barghorn, Stefan, Schmidt, Boris, Anumala, Upendra Rao, Hillen, Heinz, Klein, Corinna, Herms, Jochen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2014
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4240293/
https://www.ncbi.nlm.nih.gov/pubmed/25281869
http://dx.doi.org/10.1093/brain/awu280

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4240293/
https://www.ncbi.nlm.nih.gov/pubmed/25281869
http://dx.doi.org/10.1093/brain/awu280

Ejemplares similares